Professor Sherif El-Khamisy
Director of Institute of Cancer Therapeutics, Associate Dean Research and Innovation
Expertise: Cancer, DNA healing, DNA ageing, chromosomal single strand break repair
The Institute of Cancer Therapeutics (ICT) is a multidisciplinary team of researchers at the University of Bradford working together to research, develop and commercialise new cancer treatments. It is one of only a few centres in the UK with the research tools and expertise in-house to progress anti-cancer medicines and biomarkers from concept to clinic.
The ICT is world-renowned for research, training and partnership with industry. Working closely with prestigious universities including Stanford, Harvard, Oxford and Cambridge, along with Bradford Royal Infirmary, St James’s University Hospital, Leeds and the Royal Hallamshire Hospital, Sheffield, it has more than 30 years’ experience in drug discovery, pharmacology, metabolite profiling and pharmacokinetics.
As a pharmacist, Professor El-Khamisy’s work has led to the discovery of novel genetic pathways, influenced healthcare practice and developed new technologies.
His most recent work has been the discovery of a DNA protein ‘switch’ that could help in the treatment of cancer and dementia. He has also looked at the unique DNA repair mechanism of naked mole rats and the part it could play in treating cancer and dementia.
View all experts in: Cancer, DNA research and pharmacology.